Geriatrics News

Healio has compiled June’s most-read news in dermatology.

Healio has compiled April’s most-read news in dermatology.

Actinic keratosis remains a public health problem for older adults, occurring in approximately three of every 10 Medicare recipients, according to a research letter published in JAMA Dermatology.

Nomacopan was well tolerated and beneficial in patients with bullous pemphigoid, according to phase 2a clinical trial results.

Researchers identified three different clusters of bullous pemphigoid, the most common autoimmune blistering disorder, according to a study published in the Journal of American Academy of Dermatology.

The humoral response to BP180 and BP230 antigens is weakened in certain patients with gliptin-associated bullous pemphigoid, according to a study.

Patients with bullous pemphigoid experienced increases in cardiovascular mortality risk at 1, 3 and 5 years compared with matched controls, according to a study.

A multi-continental meta-analysis showed high mortality rates for patients with bullous pemphigoid.

Novel compounds 4’-acetoxy resveratrol and equol were associated with improvements in eight skin parameters in a cohort of postmenopausal women, according to a study.